Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

JW Shinyak Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

JW Shinyak Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ATGen Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ATGen Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Chabiotech Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chabiotech Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

iNtRON Biotechnology Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

iNtRON Biotechnology Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

DNA Link Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

DNA Link Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ST Pharm Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ST Pharm Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pharmswell Bio Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmswell Bio Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nibec Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nibec Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

DHP Korea Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

DHP Korea Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioleaders Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioleaders Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Green Cross Medical Science Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Green Cross Medical Science Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SillaJen, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SillaJen, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

GL Pharm Tech Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GL Pharm Tech Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

KolmarBNH Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KolmarBNH Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caregen Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caregen Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mezzion Pharma Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mezzion Pharma Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clinigen Group Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clinigen Group Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Faron Pharmaceuticals Oy Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Faron Pharmaceuticals Oy Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PureTech Health PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PureTech Health PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ergomed plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ergomed plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oxford Biodynamics PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oxford Biodynamics PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Indivior PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Indivior PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MaxCyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MaxCyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Optibiotix Health PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Optibiotix Health PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Circassia Pharmaceuticals plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Circassia Pharmaceuticals plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

C4X Discovery Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

C4X Discovery Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Horizon Discovery Group PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Discovery Group PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioventix PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioventix PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Midatech Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Midatech Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Shield Therapeutics PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Shield Therapeutics PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Venture Life Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venture Life Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

IXICO plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IXICO plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Collagen Solutions plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Collagen Solutions plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Science in Sport plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Science in Sport plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oryzon Genomics SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oryzon Genomics SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Laboratorio Reig Jofre SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorio Reig Jofre SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pharma Mar SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharma Mar SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

1nkemia IUCT Group SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

1nkemia IUCT Group SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Otcpharm Pao Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otcpharm Pao Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Applied Genetic Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Applied Genetic Technologies Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amphastar Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amphastar Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Merrimack Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merrimack Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Voyager Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Voyager Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Medpace Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medpace Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Xencor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xencor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aeglea Bio Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aeglea Bio Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bluebird bio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bluebird bio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PRA Health Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PRA Health Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Selecta Biosciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Selecta Biosciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Revance Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Revance Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1